Past Announcements

Editor search: Journal of Oncology Practice

ASCO is seeking candidates for the position of Editor-in-Chief for Journal of Oncology Practice. JOP includes articles on quality of care, practice organization and management, health services, legislative and legal issues, and business-related concerns for practicing oncologists. The Editor-in-Chief is responsible for oversight of six issues of approximately 58 editorial pages each. Candidates must be ASCO members.

The Editor-in-Chief’s five-year term will begin in September 2008. Members of the Clinical Practice Committee and the Publications Committee will recommend a candidate for approval by the ASCO President and Board of Directors.

By May 23, 2008, interested candidates should submit a curriculum vitae and letter of interest that includes a brief statement of their vision for JOP. ASCO members may also nominate candidates for the position. Submit letters of interest and nominations to:

Terry Van Schaik
Director of Journal Publications
ASCO
330 John Carlyle St., Suite 300
Alexandria, VA 22314

25th Anniversary Timeline Now Online

Follow JCO through the years as we celebrate our 25th anniversary. Look back at editorial leaders, editorial innovations, subscriber growth,
the advent of JCO.org, global translations, and self-publishing.

JCO Impact Factor Increases to 13.598

JCO’s impact factor increased from 11.81 to 13.598, as reported by Thomson Scientific in its 2006 Journal Citation Report. Of 126 oncology journals monitored worldwide, JCO ranks fifth (up from sixth) by impact factor and second by total citations, with 71,800 citations made to published articles—almost 13,000 more than in the previous year. An impact factor is a measure of how often the average article in a journal has been cited within a given year. In addition, JCO’s immediacy index, which measures citations last year to articles published last year (not included in the impact factor calculation), rose to 3.485, the highest of any clinical oncology journal. Daniel G. Haller, editor-in-chief of JCO, said, “JCO owes this continuing improvement to the editors and editorial staff, as well as the guidance of the Editorial Board, the support of the society, and the enormous contributions of authors and reviewers. JCO’s 2006 impact factor, total citations, and immediacy index reflect the Journal’s continued success in delivering content that strengthens expertise, improves practice, advances medical research, and supplements academic teaching.”

2007 Annual Meeting Abstracts

If you could not make it to the 2007 ASCO Annual Meeting or just want to continue your learning, JCO has a new feature just for you. The Journal is now providing subscribers with links to ASCO Annual Meeting abstracts.

Article Translations added to JCO

The editors of JCO are pleased to announce the addition of translated content to JCO.org. Beginning in March 2007, JCO subscribers around the world will be able to read selected articles translated into one or more of the following languages: Chinese, Hungarian, Polish, Russian, Spanish, and Turkish. These are articles from the printed international editions, which often have limited circulation. Through the Web site, any subscriber may access the content. In addition, once the original article is 12 months old, access will be open to all. Readers can browse the articles available by selecting the “Translations” tab under the Search/Browse bar. From there, readers can select the language of interest to display the list of articles accessible in that language. Providing translated articles is another example of JCO’s commitment to broad availability of high-impact research for oncologists worldwide.

Visit JCO at the ASCO Annual Meeting

We invite you to visit us at the ASCO Annual Meeting in Chicago, IL (June 1-5, 2007), where we will have two exhibit booths set up for your convenience – one on Publisher’s Row (booth no. 5102) and one inside the main ASCO booth (booth no. 7000). Stop by and receive a complimentary JCO gift – this year’s JCO lapel pin – and copies of our recent issues. Learn about submission requirements and our online manuscript processing system (http://submit.jco.org). Find out about JCO’s international editions, including the five new editions launched earlier this year. Sign up and subscribe to JCO, or renew your subscription. JCO staff will be on hand to assist you and answer any of your questions. We look forward to seeing you!

Submit Your Translational Oncology Manuscripts to JCO

Translational Oncology manuscripts are now being accepted for publication in JCO. The manuscripts may represent any clinical disciplines and may include such research disciplines as cancer biomarkers, angiogenesis, receptor-based therapy, epigenetics, signal transduction, genomics, proteomics, and gene profiling. Translational Oncology articles originally appeared in their own separate issues as part of the 2006 JCO Special Series. These articles have been so well-received that for 2007, they will be moved to the regular issues of JCO. Mary L. Disis, MD, JCO’s Deputy Editor, is spearheading the effort to transition Translational Oncology articles to the 24 regular issues of JCO. To discuss the suitability of your Translational Oncology manuscript for submission to the JCO, contact Dr Disis at disism{at}asco.org.

JCO Announces New Requirement for Registration of Clinical Trials

Any clinical trial reported in a Journal submission for which patient enrollment begins on or after November 1, 2006 must be registered in a public database prior to manuscript submission. Authors will have six months from the first patient enrollment to register the trial, but registration prior to enrollment is recommended. This registration policy applies to prospective, randomized, controlled trials only. JCO will accept registration in any public database that meets the World Heath Organization’s minimal data set. Currently, the ICMJE web site lists the following registries as fully compliant:

• www.actr.org.au
• www.clinicaltrials.gov
• www.ISRCTN.org
• www.umin.ac.jp/ctr/index/htm
• www.trialregister.nl

JCO 2005 Impact Factor Increases to 11.810

The Institute for Scientific Information (ISI), a division of Thomson Corporation, has released the 2005 journal impact factors. JCO is rated at 11.810 -- an increase of two points over the 2004 impact factor of 9.835. Of 123 oncology journals worldwide, JCO is ranked sixth by impact factor and second by total cites, with more than 59,000 citations made to published articles. An impact factor is a measure of how often the average article in a journal has been cited within a given year. JCO's 2005 impact factor and total cites reflect the Journal's continued success in serving the clinical oncology community by providing the most important and timely peer-reviewed research available.

Personal Folders Added to JCO.org

Individual subscribers to JCO now have the option of creating personal folders online to save important articles or to recreate frequently used searches. To create and use Personal Folders, simply open the Save to My Personal Folders link that can be found in the box of JCO Services to the right of each article viewed. Then, simply check the box to add that article to your personal folder for future reference. It's like having a virtual file cabinet at your fingertips with favorite and must-review articles. To try this new upgrade to JCO.org, log on to JCO.org, click on My JCO at the top of the page, and then click on Personal Folders. Access to Personal Folders requires a login to JCO.org.

JCO Updates the Information for Contributors

The Journal has made significant changes to the Information for Contributors section. These changes are intended to expedite the peer-review process and promote consistent submissions to the JCO. The most substantial changes include:

• Requirement of an individual unique e-mail address for each author
• Limitations on the total number of figures and tables
• Section dedicated to statistical guidelines
• Requirement for a CONSORT diagram for randomized clinical trials

Read the complete Information for Contributors online. If you have any questions about these changes or about the submission process, please send an e-mail to jco@asco.org or call (703) 797-1900.

JCO Announces Launch of Middle Eastern Edition in Print

Beginning in March 2006, selected articles from JCO will be republished and distributed in print to oncologists in the Middle East--specifically, Lebanon, Jordan, Saudi Arabia, United Arab Emirates, Oman, Qatar, Bahrain, Kuwait, Yemen, Iraq , Syria, and Egypt. Nagi S. El Saghir, MD, FACP, will serve as editor. Dr El Saghir is Clinical Associate Professor of Medicine in the Department of Internal Medicine, Division of Hematology-Oncology, at the American University of Beirut Medical Center in Lebanon. The Middle Eastern edition will be published monthly. JCO Editor-in-Chief Daniel Haller, MD, commented "the launch of the JCO Middle-Eastern edition will help to further the ASCO mission of advancing the education of physicians in the care of patients with cancer by broadening their scope of available cancer research."

Dr. Daniel Haller Appointed to Second 5-Year Term as JCO Editor-in-Chief

The ASCO Board of Directors has unanimously appointed Daniel G. Haller, MD, to a second 5-year term as Editor-in-Chief of JCO, effective June 2006. Dr Haller was first appointed JCO Editor in June 2001. In his first term, Dr Haller has oversaw a large growth in circulation and manuscript submissions, the move to ASCO self-publishing in 2003, the launch of the electronic manuscript submission system in 2004, and an increase in frequency to 36 issues owing to the launch of 12 Special Series issues in 2005.

JCO Correspondence Section To Be Modified in January ‘06

With the dramatic increase in the number of high-quality manuscript submissions, the JCO has seen an attendant increase in the number of correspondence submissions. The JCO welcomes correspondence as an important venue for dialogue among the clinical research community. However, to apportion sufficient pages for original research, the JCO is changing how it will publish correspondence. (read more)

JCO Legacy Archive Now Available

JCO is pleased to announce the launch of the JCO Legacy Archive –- online back issues of JCO from volume 1, number 1 (January 1983) through volume 16, number 12 (December 1998.) JCO offers the Legacy Archive as a reader benefit to ASCO members and other individual subscribers. Institutional subscribers will pay a nominal, one-time fee for permanent access. Before the completion of this project, only abstracts were available for content dated 1983 through 1998. Now, PDFs for this back content can be browsed or will be returned in search results, allowing researchers to build a complete history of much of the significant oncology research in the world. To view the JCO Legacy Archive, click here.

JCO is pleased to announce that its impact factor covering articles published in 2004 now stands at 9.835, which places it sixth out of 115 oncology journals worldwide as ranked by the Institute for Scientific Information (ISI), a division of Thomson Corporation. (read more)

You may have noticed a new timesaving feature available on ASCO.org and JCO.org. (Or better yet, you may not have noticed.) ASCO members no longer have to sign in twice when moving between password-protected areas of ASCO.org and JCO.org. ASCO has instituted “single sign-on” between the two sites. The best news is that you do not have to do anything -- it happens automatically. It’s automatic and behind the scenes. (read more)

The new Special Series of the Journal of Clinical Oncology (JCO), ASCO’s flagship journal, continues with its first issue in the Special Series on Molecular Oncology. The print issue will be mailed and made available on JCO.org on Thursday, February 10. In the meantime, several articles from the issue can be accessed through the Early Release page of JCO.org. (read more)

If you could not attend the 2004 ASCO Annual Meeting, but still wish to experience the unparalleled advantage of in-person learning, JCO has a new feature for you. JCO is now providing subscribers with links to the audio and video presentations of ASCO Annual Meeting abstracts. (read more)

Beginning with the November 15, 2004 issue, JCO provides corresponding authors with a link to ten electronic reprints ("e-prints") of their articles at no charge. The link sent to authors may be distributed via e-mail to colleagues, regardless of whether the recipients are JCO subscribers. (read more)

On September 3rd, the National Institutes of Health (NIH) released a draft proposal to provide public access to studies supported by NIH funds. NIH requested public reaction to the proposal, which would grant free access via PubMed Central, 6 months after publication of the study in a peer-reviewed journal. The proposal is available on the NIH website at http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-04-064.html. ASCO provided comments to NIH in a November 16th letter. To read the ASCO letter, please click here.

JCO is pleased to announce that we have begun offering free trial subscriptions to the world’s foremost peer-reviewed biomedical journal focusing on clinical cancer research. (read more)

Online Manuscript Submission System Now Available

The JCO Editorial Office has worked with HighWire Press for the past six months to develop an online manuscript submission and peer review system that will serve the needs of authors, reviewers, and editors. The new system is now available at http://submit.jco.org. (read more)

JCO.org now features the ability for subscribers to create PowerPoint slides from figures available within full-text articles. Click on any figure in any full-text article and follow the instructions for creating presentation slides for teaching and other noncommercial use. This feature is an important new subscriber benefit. ASCO members or non-member subscribers may visit http://www.jco.org/cgi/content/full/22/15/3003/F1 to view an example.

For 2005, we are introducing a tiered subscription structure whereby institutional type determines the subscription rate. 2005 prices are in effect September 1, 2004 through August 31, 2005. Please note that this new structure is not an FTE or "full-time equivalent" employee pricing model. Click here to see the 2005 JCO Institutional Subscription Rate Card, including definitions of the tiers. (read more)

JCO is pleased to announce that its impact factor for 2003 has increased to 10.9. JCO’s 2002 impact factor was 9.9. This 10 percent increase reflects JCO’s continued success in serving the clinical oncology community by providing the most important and timely peer reviewed research available. JCO’s 2003 impact factor ranks it number 5 out of 115 oncology journals worldwide as ranked by the Institute for Scientific Information (ISI). Impact factors and journal rankings are calculated yearly by the ISI, which is part of the Thomson Corporation. (read more)

New Author Disclosure Declaration Forms Required With All Manuscript Submissions

Please see the new Author Disclosure Declaration Forms in the April 15 print issue or at http://www.jco.org/misc/ifora.dtl. (read more)

JCO’s Research To Be Free One Year After Publication/ASCO Signs "Washington, D.C. Principles for Free Access to Science"
Read the full story